Asia Pacific Veterinary Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia-Pacific Veterinary Vaccine Market Report is segmented by Vaccine Type (Livestock Vaccines and Companion Animal Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies), and Geography (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific). The market size and forecast values are provided in terms of (USD) for all the above segments.

Asia Pacific Veterinary Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

APAC Veterinary Vaccine Market Size

View Global Report
Asia-Pacific Veterinary Vaccine Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 6.12 %
Market Concentration Medium

Major Players

Asia-Pacific Veterinary Vaccine Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Veterinary Vaccine Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

APAC Veterinary Vaccine Market Analysis

The Asia-Pacific Veterinary Vaccine Market is expected to register a CAGR of 6.12% during the forecast period.

COVID-19 has led to increased adoption of pet animals during the pandemic. For instance, as per the data published by the National Institute of Health in March 2021, it has been observed that pet adoption increased in Asian countries during the pandemic, and initial vaccinations on pets were done regularly. Moreover, according to an article published by Frontiers in May 2021, a study was conducted in countries such as Australia, the United States, Canada, New Zealand, the United Kingdom, Singapore, the Philippines, and Malaysia, which showed that during the last five years, the pet adoption rate was the highest during the early pandemic phase. Though the pet adoption rate increased during the pandemic, in several countries, the vaccination of dogs for diseases such as rabies was reduced. For instance, according to an article published by Frontiers in July 2022, a study was conducted in 48 countries in Asia and Africa, which showed that the mass dog vaccination for rabies control was heavily impacted during the early pandemic, and it was carried out as planned in just 5% of surveyed countries. Thus, the veterinary vaccines market was affected significantly as a result of COVID-19. However, as the pandemic has subsided, the pet adoption rate and the vaccination rate have gone back to normal, thus the studied market is expected to have stable growth during the forecast period.

The key factors propelling the growth of this market are the increasing incidences of livestock and zoonotic diseases, veterinary vaccination initiatives taken by various government agencies, and animal associations, as well as by the leading players operating in the Asia-Pacific region. For instance, according to a study published in the Infection Ecology & Epidemiology in September 2021, one of the most dangerous zoonotic diseases in the world is salmonellosis. Salmonella prevalence in animals and risk factors for increased transmission of salmonella spp. from animals to people were evident. Hence, with the emergence of such diseases in animals, the market studied is expected to witness growth over the forecast period.

Moreover, according to an article published by SpringerLink in May 2021, the canine adenovirus (CAV) is said to have two distinct serotypes CAV1 and CAV2. The CAV1 targets the digestive tract tissue and it is the causative agent of infectious canine hepatitis (ICH) (also called Rubarth's disease), a life-threatening disease of puppies, and the CAV2 replicates in respiratory epithelium and is associated with respiratory diseases. A study was conducted on 26 dogs in India which showed the presence of a novel CAV2 strain in dogs that is genetically distinct from other Indian CAV2 strains which are currently circulating in India. The emergence of a such highly infectious novel strain of viruses among the canine population is expected to boost the adoption of vaccines during the forecast period of the study.

Furthermore, according to an article published by Recent Advances in Canine Medicines in October 2021, canine parvovirus-2 (CPV-2) is considered a highly contagious and key entero-pathogen affecting the canine population. In India, the CPV-2a variant of the virus has recently become the most prevailing antigenic type among all variants, and the emergence of such new antigenic variants that differ significantly from the current vaccine strains is a matter of concern for the efficacy of available vaccines. Hence, the emergence of such new virus strains is expected to create more demand for veterinary vaccines.

However, high storage costs for vaccines are expected to hinder the market growth.

APAC Veterinary Vaccine Industry Overview

The Asia-Pacific veterinary vaccine market is moderately consolidated and consists of several major players. In terms of market share, a few of the major players currently dominate the market. Companies, like Zoetis Inc., Merck & Co. Inc., Virbac Inc., and Boehringer Ingelheim International GmbH, hold a substantial market share in the Asia-Pacific veterinary vaccine market.

APAC Veterinary Vaccine Market Leaders

  1. Boehringer Ingelheim International GmbH

  2. Zoetis Inc.

  3. Merck & Co. Inc.

  4. Virbac SA

  5. Elanco

  6. *Disclaimer: Major Players sorted in no particular order
Picture4.png
Need More Details on Market Players and Competiters?
Download PDF

APAC Veterinary Vaccine Market News

  • In June 2022, the Union Minister of Agriculture & Farmers' Welfare, Shri Narendra Singh Tomar, launched Animal Vaccine and other Diagnostic Kits developed by the ICAR-National Research Centre on Equines in Hisar, Haryana, India.
  • In June 2022, the Australian Pesticides and Veterinary Medicines Authority (APVMA) approved an emergency permit (PER92219) for a vaccine to protect pet rabbits against the rabbit hemorrhagic disease (calicivirus) virus type 2 strain (RHDV2).

APAC Veterinary Vaccine Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Diseases in Animals
    • 4.2.2 Initiatives by Various Government Agencies, Animal Associations, and Leading Players
  • 4.3 Market Restraints
    • 4.3.1 High Storage Costs for Vaccines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size - Value in USD million)

  • 5.1 By Vaccine Type
    • 5.1.1 Livestock Vaccines
    • 5.1.1.1 Bovine Vaccines
    • 5.1.1.2 Poultry Vaccines
    • 5.1.1.3 Porcine Vaccines
    • 5.1.1.4 Other Livestock Vaccines
    • 5.1.2 Companion Animal Vaccines
    • 5.1.2.1 Canine Vaccines
    • 5.1.2.2 Feline Vaccines
    • 5.1.2.3 Equine Vaccines
  • 5.2 By Technology
    • 5.2.1 Live Attenuated Vaccines
    • 5.2.2 Inactivated Vaccines
    • 5.2.3 Toxoid Vaccines
    • 5.2.4 Recombinant Vaccines
    • 5.2.5 Other Technologies
  • 5.3 Geography
    • 5.3.1 China
    • 5.3.2 Japan
    • 5.3.3 India
    • 5.3.4 South Korea
    • 5.3.5 Australia
    • 5.3.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boehringer Ingelheim International GmbH
    • 6.1.2 Ceva Sante Animale
    • 6.1.3 Elanco
    • 6.1.4 Hester Biosciences Ltd
    • 6.1.5 HIPRA
    • 6.1.6 Merck & Co.
    • 6.1.7 Phibro Animal Health Corp.
    • 6.1.8 Virbac SA
    • 6.1.9 China Animal Husbandry Industry Co., Ltd.
    • 6.1.10 Tianjin Ringpu Bio-Technology Co.,Ltd.
    • 6.1.11 Jinyu Biotechnology Co., Ltd.
    • 6.1.12 Zoetis Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

APAC Veterinary Vaccine Industry Segmentation

As per the scope of this report, veterinary vaccines are used to immunize domestic and livestock animals. The Asia-Pacific Veterinary Vaccine Market is segmented by Vaccine Type (Livestock Vaccines and Companion Animal Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies), and Geography (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

By Vaccine Type Livestock Vaccines Bovine Vaccines
Poultry Vaccines
Porcine Vaccines
Other Livestock Vaccines
Companion Animal Vaccines Canine Vaccines
Feline Vaccines
Equine Vaccines
By Technology Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Technologies
Geography China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

APAC Veterinary Vaccine Market Research FAQs

What is the current Asia-Pacific Veterinary Vaccine Market size?

The Asia-Pacific Veterinary Vaccine Market is projected to register a CAGR of 6.12% during the forecast period (2025-2030)

Who are the key players in Asia-Pacific Veterinary Vaccine Market?

Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co. Inc., Virbac SA and Elanco are the major companies operating in the Asia-Pacific Veterinary Vaccine Market.

What years does this Asia-Pacific Veterinary Vaccine Market cover?

The report covers the Asia-Pacific Veterinary Vaccine Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Veterinary Vaccine Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

APAC Animal Vaccine Industry Report

Statistics for the 2025 Asia-Pacific Veterinary Vaccine market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Veterinary Vaccine analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.